Unusual Histopathological Findings in Mechanically Removed Stroke Thrombi - A Multicenter Experience.

adipocyte-like calcification collagen extracellular DNA ischemic stroke mechanical thrombectomy myofibroblast myxomatous

Journal

Frontiers in neurology
ISSN: 1664-2295
Titre abrégé: Front Neurol
Pays: Switzerland
ID NLM: 101546899

Informations de publication

Date de publication:
2022
Historique:
received: 31 12 2021
accepted: 20 04 2022
entrez: 6 6 2022
pubmed: 7 6 2022
medline: 7 6 2022
Statut: epublish

Résumé

Several studies have investigated the histopathology of mechanically retrieved thrombi from stroke patients. Thrombi with unusual components constitute about 1-2% of all stroke thrombi in clinical practice. Knowledge about these rare components is limited. To characterize the histopathology of unusual stroke thrombi from a real-world setting with relation to clinical presentation, patient characteristics and procedural aspects of mechanical thrombectomy. One-thousand and eight thrombi retrieved from stroke patients with mechanical thrombectomy at three different hospitals were retrospectively reviewed for unusual histological components. Fifteen thrombi were included in the study for further histopathological analysis. Clinical data and data on procedural aspects were collected. We identified six cases with large amounts of extracellular DNA, of which three were calcified. All six cases except one received anticoagulant therapy. We describe two types of calcifications that differ with respect to general calcification morphology, von Kossa staining pattern, macrophage immunophenotype and presence of multinucleated giant cells. Cholesterol-rich ( In our retrospective multicenter study, we characterized stroke thrombi histopathologically and found subgroups of thrombi defined by presence of rarely seen components. These defined subgroups showed relation to underlying cardiovascular disease, patient characteristics, and mechanical thrombectomy technique. Knowledge about these components may increase our understanding of stroke pathophysiology and influence interventional procedures.

Sections du résumé

Background UNASSIGNED
Several studies have investigated the histopathology of mechanically retrieved thrombi from stroke patients. Thrombi with unusual components constitute about 1-2% of all stroke thrombi in clinical practice. Knowledge about these rare components is limited.
Objectives UNASSIGNED
To characterize the histopathology of unusual stroke thrombi from a real-world setting with relation to clinical presentation, patient characteristics and procedural aspects of mechanical thrombectomy.
Methods UNASSIGNED
One-thousand and eight thrombi retrieved from stroke patients with mechanical thrombectomy at three different hospitals were retrospectively reviewed for unusual histological components. Fifteen thrombi were included in the study for further histopathological analysis. Clinical data and data on procedural aspects were collected.
Results UNASSIGNED
We identified six cases with large amounts of extracellular DNA, of which three were calcified. All six cases except one received anticoagulant therapy. We describe two types of calcifications that differ with respect to general calcification morphology, von Kossa staining pattern, macrophage immunophenotype and presence of multinucleated giant cells. Cholesterol-rich (
Conclusion UNASSIGNED
In our retrospective multicenter study, we characterized stroke thrombi histopathologically and found subgroups of thrombi defined by presence of rarely seen components. These defined subgroups showed relation to underlying cardiovascular disease, patient characteristics, and mechanical thrombectomy technique. Knowledge about these components may increase our understanding of stroke pathophysiology and influence interventional procedures.

Identifiants

pubmed: 35665052
doi: 10.3389/fneur.2022.846293
pmc: PMC9157388
doi:

Types de publication

Journal Article

Langues

eng

Pagination

846293

Informations de copyright

Copyright © 2022 Aspegren, Staessens, Vandelanotte, Desender, Cordonnier, Puy, Bricout, De Meyer, Andersson and Arnberg.

Déclaration de conflit d'intérêts

The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.

Références

J Stroke Cerebrovasc Dis. 2014 Oct;23(9):e417-9
pubmed: 25174564
J Leukoc Biol. 2017 Sep;102(3):775-781
pubmed: 28465447
Stroke. 2002 Sep;33(9):2243-6
pubmed: 12215594
Pract Neurol. 2018 Apr;18(2):134-136
pubmed: 29288212
Stroke. 2020 Sep;51(9):2810-2816
pubmed: 32811390
Cell Death Discov. 2018 Jun 28;4:6
pubmed: 30062055
J Neurol Sci. 2021 Aug 15;427:117550
pubmed: 34175777
Sci Rep. 2019 Oct 31;9(1):15762
pubmed: 31673032
Int Immunol. 2020 May 8;32(5):359-368
pubmed: 31879779
Proc Natl Acad Sci U S A. 2010 Sep 7;107(36):15880-5
pubmed: 20798043
Neurocrit Care. 2007;7(3):241-6
pubmed: 17805494
N Engl J Med. 2015 Jun 11;372(24):2285-95
pubmed: 25882376
Dalton Trans. 2014 Jan 7;43(1):317-27
pubmed: 24105025
Front Immunol. 2021 Feb 24;12:621311
pubmed: 33717121
Science. 2018 Feb 23;359(6378):
pubmed: 29472455
Blood. 2014 Oct 2;124(14):2173-83
pubmed: 25082876
N Engl J Med. 2015 Jan 1;372(1):11-20
pubmed: 25517348
Int J Stroke. 2020 Jul;15(5):467-476
pubmed: 31679478
N Engl J Med. 2015 Mar 12;372(11):1019-30
pubmed: 25671798
Haematologica. 2020 Jan 31;105(2):498-507
pubmed: 31048352
Lancet. 1993 Mar 27;341(8848):784-7
pubmed: 8096000
Thromb J. 2021 Feb 22;19(1):11
pubmed: 33618719
Ann Neurol. 2008 Sep;64(3):344-8
pubmed: 18570298
J Neurointerv Surg. 2014 Jan;6(1):e1
pubmed: 22791184
J Neurointerv Surg. 2019 Mar;11(3):232-236
pubmed: 30097483
N Engl J Med. 2015 Mar 12;372(11):1009-18
pubmed: 25671797
Circ Res. 2020 Apr 10;126(8):e37-e52
pubmed: 32089086
Wound Repair Regen. 2021 Jul;29(4):548-562
pubmed: 34107123
J Neurol Sci. 2020 Jan 15;408:116573
pubmed: 31731112
Cell Death Dis. 2016 Dec 1;7(12):e2495
pubmed: 27906172
N Engl J Med. 2015 Jun 11;372(24):2296-306
pubmed: 25882510
J Stroke Cerebrovasc Dis. 2021 Dec;30(12):106127
pubmed: 34592611
Stroke. 1993 Jan;24(1):35-41
pubmed: 7678184
Atherosclerosis. 2017 Apr;259:60-67
pubmed: 28292668
BMJ Open. 2016 Jun 21;6(6):e011947
pubmed: 27329444
J Neurol Sci. 2021 Oct 15;429:117617
pubmed: 34461551

Auteurs

Oskar Aspegren (O)

Department of Pathology and Cancer Diagnostics, Karolinska University Hospital, Stockholm, Sweden.
Department of Oncology-Pathology, Karolinska Institutet, Stockholm, Sweden.

Senna Staessens (S)

Laboratory for Thrombosis Research, KU Leuven Campus Kulak Kortrijk, Kortrijk, Belgium.

Sarah Vandelanotte (S)

Laboratory for Thrombosis Research, KU Leuven Campus Kulak Kortrijk, Kortrijk, Belgium.

Linda Desender (L)

Laboratory for Thrombosis Research, KU Leuven Campus Kulak Kortrijk, Kortrijk, Belgium.

Charlotte Cordonnier (C)

University of Lille, INSERM, CHU Lille, U1172-Lille Neuroscience & Cognition (LilNCog), Lille, France.

Laurent Puy (L)

University of Lille, INSERM, CHU Lille, U1172-Lille Neuroscience & Cognition (LilNCog), Lille, France.

Nicolas Bricout (N)

Department of Interventional Neuroradiology, CHU Lille, Lille, France.

Simon F De Meyer (SF)

Laboratory for Thrombosis Research, KU Leuven Campus Kulak Kortrijk, Kortrijk, Belgium.

Tommy Andersson (T)

Department of Medical Imaging, AZ Groeninge, Kortrijk, Belgium.
Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Department of Neuroradiology, Karolinska University Hospital, Stockholm, Sweden.

Fabian Arnberg (F)

Department of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Department of Neuroradiology, Karolinska University Hospital, Stockholm, Sweden.

Classifications MeSH